Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Archiv Der Pharmazie|December 18, 2024
5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidatesEster Colarusso, Gianluigi Lauro, Marianna Potenza, et al.Journal of Medicinal Chemistry|June 25, 2005
Pyrrolo[1,5]benzoxa(thia)zepines as a new class of potent apoptotic agents. Biological studies and identification of an intracellular location of their drug targetMargaret M Mc Gee, Sandra Gemma, Stefania Butini, et al.Antioxidants (Basel, Switzerland)|March 25, 2022
Extra Virgin Olive Oil Extracts of Indigenous Southern Tuscany Cultivar Act as Anti-Inflammatory and Vasorelaxant NutraceuticalsLuca Pozzetti, Francesca Ferrara, Ludovica Marotta, et al.ACS Infectious Diseases|July 26, 2022
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery ApproachTheo Battista, Stefano Federico, Simone Brogi, et al.European Journal of Medicinal Chemistry|December 3, 2022
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditionsAlessandro Papa, Silvia Pasquini, Francesca Galvani, et al.Journal of Medicinal Chemistry|January 28, 2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutationsStefania Butini, Margherita Brindisi, Sandro Cosconati, et al.Journal of Medicinal Chemistry|November 11, 2005
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activityCaterina Fattorusso, Sandra Gemma, Stefania Butini, et al.Archiv Der Pharmazie|January 28, 2025
Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P3Sara Rossi, Graziano Deidda, Lia Fiaschi, et al.ACS Pharmacology & Translational Science|July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Sara Rossi, Valentina Giudice, et al.Journal of Medicinal Chemistry|January 5, 2026
Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In VivoGabriele Carullo, Federica Falbo, Valeria Tudino, et al.Pageof 5